Thus, an HCC that is under assault might quickly upregulate PD-L1, PD-L2, or other checkpoints (like HLA-E to engage NKG2A on NK cells, or CD274 which encodes PD-L1) as a shield [2]. This evidence concerns the gene CD274 and hepatocellular carcinoma.